Institut Catala D'oncologia — Clinical Trial Site

924 Registered trials

494 Currently recruiting

Organisation

Institut Catala D'oncologia

Location

L'hospitalet De Llobregat, Spain

Identifier

ORG-100030394

Address

Carretera Canyet S/n, 08916, Spain

Departments

-
#1301: Oncologia
#1402: Oncología
#2001:Oncology
#2031:Hematology
#2455: Oncologia
#2900:Hematología Clínica
#3904; Hematología Clínica
#4007:Hematología Clínica
#4009:Hematología Clínica
#6000:Oncología
#6003: Servicio Oncología
#7000: Hematología
#752; Oncologia
#9007: Oncology
#93158006: Oncología Médica
#98358006: Oncology
#E3032401: N/A
034036: Oncología Médica
1211:Oncología Médica
1304: Hematología
1321: Hematologia
1501 Oncología
1600 Oncology
172406: Hematología
172411: Hematologia
1803: Hematología
2101: Department Oncology
2201: Oncologia
2909: Hematology
2911: Hematology
3003:Servicio de Oncologia
3203: Hematologia
3211: Hematologia
34005: Oncologia
34009: Oncologia
34013: Oncología Médica
3404: Servicio de Hematologia
3603; Oncología Médica
4502:Servicio Oncología
6001:Oncologia Médica
609 : Oncología Médica
7001: Oncologia
7001: Oncology
7002: Oncologia
7003: Oncología Médica
7004: Oncología Médica
7005: Oncología Médica
7006: Oncologia
7007: Oncología Médica
7008: Oncologia
7010: Oncología Médica
7113:Oncología
724002; Hematología
724002: Hematología
724013: Oncologia
724023: Oncología Médica
743: Hematologia
arly Drug Development Group - Medical Oncology Department
Cancer Epidemiology Research Programme PREC
Clinic Hematology
Clinical Haematology
Clinical Haematology Service
Clinical Haematology Service/ Servicio de hematología clínica
Clinical Hematology
Clinical Hematology department
Clinical Hematology Service
Clinical research department
Clinical research unit
Departamento de Oncología Médica
Department de Hematology Clinical
Department of Clinical Hematology
Department of Hematology
Department of Medical Oncology
Department of Oncology
Division of Medical Oncology, Head and Neck Cancer Unit H. Duran i Reynals
Edificio de Consultas Externas, 2ª planta, Servicio de Oncología Médica
Ensayos Clinicos Oncologia
ES001A: Hematología
ES10004: Hematología
ES10006: Hematología y Hemoterapia
ES10008: Hematología
ES10013: Hematología
ES30007: Hematología
ES30008:Hematología y Hemoterapia
ESP003: Hematologia
ESP03-0: Oncologia Médica
ESP05-0: Oncologia Médica
Gastroenterology Department
Genetic Counseling Unit
Genitourinary Cancer Unit
Haematology
Haematology Department
Hemarología
Hematolgy
Hematologia
Hematologia clinica
Hematologist
hematology
Hematology and hematherapy
Hematology and Hemotherapy Service
Hematology Department
Hematology Department and Hematopoietic Stem Cell Transplant Programme
Hematology Department Lymphoma Unit
Hematology sercive
Hematology service
Hematology Unit
Hematology/Oncology
Hematopoietic Cell Transplant and Cell Therapy Unit
Hemtaology
Hospital Universitario Dr. Josep Trueta; Medical Oncology
ICO L'Hospitalet (Hospital Duran i Reynals)
Infectious Diseases Unit
Institut Català d' Oncologia
Institut Català d'oncologia
Institut Català d'Oncologia - Institut de Recerca Josep Carreras
Lymphoma Unit
Maternal
Medical Hematology
Medical Oncologist
Medical Oncology
Medical Oncology Department
Medical Oncology Departmnent
Medical Oncology Service
Medicine
N/A
NA
Onccology
Oncolgy
Oncolgy Service
Oncología
Oncología Médica
Oncologia Mèdica / Medical Oncology Department
Oncología Radioterápica
Oncología, 503
Oncology
Oncology Department
Oncology Medical
Oncology service
Oncology Service Department
Ophthalmology
ospital de Girona Dr. Josep Trueta
Phase 1 Unit. Breast Cancer Unit
Planta 4. ICO de Badalona. Ensayos Clinicos
Radiation Oncology
Radiotherapy Oncology
Radiotherapy oncology service
Sáez
Servicio de Hematologia
Servicio de Hematologia Clinica
Servicio de Oncología
Servicio de Oncologia Medica
Servicio de Oncología Médica - Area Ensayos Clínicos
Servicio Oncologia
Servicio Oncologia Medica
Thoracic Oncology
Trucco
ukn
Unidad de Ensayos Clinicos de Oncologia
Unidad de Fase 1
Unidad de Investigación Clínica
Unidad de Sarcoma y Cáncer Genitourinario
Unitat Funcional Fase 1
Z97ES10008: Hematología
Z97ES10011: Hematologia

Clinical trials at this site (924)

Search interface

A Phase 2 Trial of BDC-1001 as Single Agent and in Combination with Pertuzumab in Subjects with Human Epidermal Growth Factor Receptor 2–Pos… Ended

2023-506038-65-00 HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2–POSITIVE METAS 4 2024-04-15
Regorafenib-pembrolizumab vs. TACE/TARE in intermediate-stage HCC beyond up-to-7. Ended

2022-501969-42-00 Intermediate-stage hepatocellular carcinoma with beyond 5 2024-03-28
A Study to Evaluate Safety and Preliminary Anti-tumor Activity of Debio 0123 as Monotherapy in Adult Participants With Advanced Solid Tumors Ended

2023-504824-24-00 Arm A: Diagnosed with uterine serous carcinoma (USC) Ar 3 2024-03-15
A Trial to Investigate TransCon TLR7/8 Agonist in Combination with Pembrolizumab, TransCon TLR7/8 Agonist in Combination with TransCon IL-2 … Ended

2023-506092-10-00 Stage III-IVA Resectable Locoregionall Advanced Head an 4 2024-03-11
A Window-of-Opportunity study of hormone therapy in premenopausal women with ER-positive/HER2-negative early breast cancer. Ended

2022-503013-32-00 ER-positive/HER2-negative early breast cancer 4 2024-01-29
A Multicenter, Open-Label Clinical Trial of RVU120 in Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myelo… Ended

2023-505910-10-00 Relapsed or Refractory High-Risk Myelodysplastic Syndro 4 2024-01-23
Phase 1b safety study of xevinapant, weekly cisplatin, and radiotherapy in participants with unresected LA SCCHN Ended

2023-505796-76-00 Locally Advanced Squamous Cell Carcinoma of the Head an 3 2024-01-18
Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment Ended

2023-503919-15-00 Prostatic Neoplasms 3 2024-01-09
A Dose Escalation and Cohort Expansion Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors or Non-Hodgkin Lymphoma. Ended

2023-503739-16-00 Relapsed or refractory solid tumors or non-Hodgkin lymp 1 2023-12-20
A Study of Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma Ended

2023-503418-63-00 Head and Neck Squamous Cell Carcinoma 4 2023-11-23
Radiotherapy plus xevinapant or placebo in older patients with locally advanced head and neck cancer Ended

2022-502339-20-00 Squamous cell carcinoma of head and neck 4 2023-11-15
A Study to Evaluate CC-486 in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Cancer Partic… Ended

2023-503427-26-00 Myeloid malignancies with moderate or severe hepatic im 3 2023-11-10
A Phase 2 Study Evaluating INCB099280 in Participants With Advanced Cutaneous Squamous Cell Carcinoma Ended

2022-502476-23-00 Treatment of immunotherapy-naive patients with previous 4 2023-10-25
A Study of Samuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced HR Positive and HER2-Negative BC Ended

2023-503903-27-00 metastatic or locally advanced Hormone Receptor positiv 4 2023-10-11
A study to test the effect of Samuraciclib in Combination with Elacestrant in Participants with Hormone Receptor-positive (HR+) and Human Ep… Ended

2023-503846-30-00 Breast Cancer 9 2023-10-10
A clinical study of bemcentinib with standard of care chemoimmunotherapy in untreated advanced/metastatic non-small cell lung cancer patient… Ended

2024-511007-41-00 Untreated advanced or metastatic non-squamous non-small 9 2023-10-03
A study to investigate safety and efficacy with SAR445514 in participants with relapsed/refractory multiple myeloma (RRMM) and relapsed/refr… Ended

2022-502057-33-00 Relapsed/refractory multiple myeloma 7 2023-10-02
Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell Lymphoma (ALPHA2) Ended

2022-501927-25-00 Large B-Cell Lymphoma (LBCL) 4 2023-09-29
Phase II, multi‑cohort trial of neoadjuvant and post‑surgery IO102‑IO103 and pembrolizumab in patients with selected resectable tumors Ended

2022-502787-20-00 Melanoma and squamous cell carcinoma of the head and ne 4 2023-09-28
A Study to Evaluate the Safety and Pharmacokinetics of the Intravenous Fixed-Dose Combination (IV FDC) of Tiragolumab and Atezolizumab in Pa… Ended

2023-508489-14-00 Solid Tumors 4 2023-09-18
A dose-escalation and expansion study of the safety and pharmacokinetics of XB002 as single-agent and combination therapy in subjects with i… Ended

2023-508267-69-00 Subjects with Aadvanced solid tumors for whom life-prol 3 2023-08-11
Clinical trial of MK-7648A in adults and children with skin cancer Ended

2022-501417-31-01 melanoma 5 2023-08-01
A Study Evaluating Pharmacokinetic Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Stage III and Stage IV … Ended

2022-502620-49-00 Resected Melanoma Stage III or Stage IV 2 2023-08-01
PREOPERATIVE WINDOW OF OPPORTUNITY STUDY WITH GIREDESTRANT (GDC-9545) OR TAMOXIFEN IN PREMENOPAUSAL WOMEN WITH ER[+]/HER2[-] & KI67≥10% EARL… Ended

2023-503565-36-00 ER[+]/HER2[-] & Ki67≥10% early breast cancer (EBC) 4 2023-07-19